Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Kyt 0353
2. Kyt0353
1. Kyt0353
2. Kyt 0353
3. (2s)-2-amino-3-[4-[(5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy]-3,5-dichlorophenyl]propanoic Acid
4. (2s)-2-amino-3-(4-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic Acid
5. Refchem:164542
6. Jph203
7. 1037592-40-7
8. Nanvuranlat
9. Jph-203
10. Jph203 Free Base
11. Cedo9qxyzk
12. Unii-cedo9qxyzk
13. (s)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl)propanoic Acid
14. Jph 203
15. Mfcd30534398
16. Chembl4538666
17. L-tyrosine, O-((5-amino-2-phenyl-7-benzoxazolyl)methyl)-3,5-dichloro-
18. 1037592-40-7 (free Base)
19. (2s)-2-amino-3-(4-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy)-3,5-dichloro-phenyl)propanoic Acid
20. (2s)-2-amino-3-[4-[(5-amino-2-phenyl-1,3-benzoxazol-7-yl)methoxy]-3,5-dichloro-phenyl]propanoic Acid
21. Vrw
22. Nanvuranlat [inn]
23. C23h19cl2n3o4
24. Gtpl9347
25. Orb1296219
26. O-[(5-amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-l-tyrosine
27. Schembl17360639
28. Schembl29369044
29. Glxc-10626
30. Ex-a2559
31. Jph 203;
32. L-tyrosine, O-[(5-amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-;l-tyrosine, O-[(5-amino-2-phenyl-7-benzoxazolyl)methyl]-3,5-dichloro-
33. Bdbm50532381
34. S8667
35. Akos032945064
36. Cs-6064
37. Ac-36140
38. Bs-14324
39. Da-64663
40. Jph203 Hydrochloride, >=98% (hplc)
41. Hy-100868
42. Compound-jp [us20160279103]
43. D71159
44. O-((5-amino-2-phenyl-1,3-benzoxazol-7-yl)methyl)-3,5- Dichloro-l-tyrosine
45. (s)-2-amino-3-(4-((5-amino-2-phenylbenzo[d]oxazol-7-yl)methoxy)-3,5-dichlorophenyl) Propanoic Acid
| Molecular Weight | 472.3 g/mol |
|---|---|
| Molecular Formula | C23H19Cl2N3O4 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 7 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 125 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 626 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
68
PharmaCompass offers a list of Kyt-0353 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Kyt-0353 manufacturer or Kyt-0353 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Kyt-0353 manufacturer or Kyt-0353 supplier.
A KYT 0353 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of KYT 0353, including repackagers and relabelers. The FDA regulates KYT 0353 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. KYT 0353 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A KYT 0353 supplier is an individual or a company that provides KYT 0353 active pharmaceutical ingredient (API) or KYT 0353 finished formulations upon request. The KYT 0353 suppliers may include KYT 0353 API manufacturers, exporters, distributors and traders.
KYT 0353 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of KYT 0353 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right KYT 0353 GMP manufacturer or KYT 0353 GMP API supplier for your needs.
A KYT 0353 CoA (Certificate of Analysis) is a formal document that attests to KYT 0353's compliance with KYT 0353 specifications and serves as a tool for batch-level quality control.
KYT 0353 CoA mostly includes findings from lab analyses of a specific batch. For each KYT 0353 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
KYT 0353 may be tested according to a variety of international standards, such as European Pharmacopoeia (KYT 0353 EP), KYT 0353 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (KYT 0353 USP).
